Search for Clinical Trial Results

Sponsored By

Fever - 136 Studies Found

Status Study
Completed Study Name: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
Condition: Marburg Hemorrhagic Fever
Date: 2012-03-27
Interventions:
  • Drug: AVI-7288

Completed Study Name: Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
Condition: Marburg Hemorrhagic Fever
Date: 2011-04-22
Interventions:
  • Drug: AVI-6003 Single intraven
Completed Study Name: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults
Condition: Hemorrhagic Fever, Ebola
Date: 2015-09-29
Interventions: Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device
Completed Study Name: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Condition: Hemorrhagic Fever, Ebola
Date: 2015-01-12
Interventions: Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients.
Completed Study Name: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
Condition:
  • Acquired Bleeding Disorder
  • Dengue Haemorrhagic Fever

Date: 2012-05-14
Interventions:
  • Drug: activated recombinant human factor VII

Completed Study Name: Experimental Ebola Vaccine Trial
Condition:
  • Hemorrhagic Fever, Ebola
  • Healthy

Date: 2003-11-04
Interventions: Drug: VRC-EBODNA012-00-VP
Not yet recruiting Study Name: African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
Condition: Ebola
Date: 2016-12-22
Interventions:
  • Biological: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine

Recruiting Study Name: Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
Condition: Ebola Virus Survivor
Date: 2016-02-24
Interventions: Drug: Favipiravir Cohort 1: Day 1 (inclusion) 4800 mg (240
Completed Study Name: GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
Condition: Persistent Ebola Virus
Date: 2016-06-28
Interventions:
  • Drug: GS-5734 Daily GS-5734 de
Active, not recruiting Study Name: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)
Condition: Prevention of Ebola Infection
Date: 2015-07-17
Interventions:
  • Biological: V920 Consistency Lot A

<<< Previous | Next >>>